HIGHLIGHTS
- What: Five clinical studies included in this analysis reported adverse reactions associated with drug therapy.
- Who: Wei Peng et al. from the Chengdu University of Traditional Chinese Medicine, China have published the article: The ef fi cacy and safety of Gukang Capsule for primary osteoporosis: a systematic review and meta-analysis of randomized clinical trial, in the Journal: (JOURNAL) of 30/09/2023
- How: Clinical data were analyzed using Review Manager 5.3. Count data were evaluated using Relative Risk (RR) and 95% Confidence Interval (CI). Subgroup analysis results showed that adding Gukang . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.